Annual Operating Expenses
$442.31 M
-$188.44 M-29.88%
December 31, 2024
Summary
- As of March 12, 2025, SAGE annual total operating expenses is $442.31 million, with the most recent change of -$188.44 million (-29.88%) on December 31, 2024.
- During the last 3 years, SAGE annual operating expenses has fallen by -$24.35 million (-5.22%).
- SAGE annual operating expenses is now -38.10% below its all-time high of $714.59 million, reached on December 31, 2019.
Performance
SAGE Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$91.67 M
-$16.13 M-14.96%
December 31, 2024
Summary
- As of March 12, 2025, SAGE quarterly total operating expenses is $91.67 million, with the most recent change of -$16.13 million (-14.96%) on December 31, 2024.
- Over the past year, SAGE quarterly operating expenses has stayed the same.
- SAGE quarterly operating expenses is now -51.91% below its all-time high of $190.61 million, reached on September 30, 2019.
Performance
SAGE Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
SAGE Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.9% | 0.0% |
| 3 y3 years | -5.2% | -27.9% |
| 5 y5 years | -38.1% | -48.0% |
SAGE Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.9% | at low | -49.1% | at low |
| 5 y | 5-year | -38.1% | at low | -49.1% | at low |
| alltime | all time | -38.1% | +4492.6% | -51.9% | +2604.8% |
Sage Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $442.31 M(-29.9%) | $91.67 M(-15.0%) |
| Sep 2024 | - | $107.80 M(-9.1%) |
| Jun 2024 | - | $118.55 M(-4.6%) |
| Mar 2024 | - | $124.31 M(+4.1%) |
| Dec 2023 | $630.76 M(+13.9%) | $119.44 M(-33.7%) |
| Sep 2023 | - | $180.06 M(+4.2%) |
| Jun 2023 | - | $172.73 M(+9.0%) |
| Mar 2023 | - | $158.53 M(+1.2%) |
| Dec 2022 | $553.86 M(+18.7%) | $156.62 M(+9.5%) |
| Sep 2022 | - | $143.03 M(+10.2%) |
| Jun 2022 | - | $129.74 M(+4.2%) |
| Mar 2022 | - | $124.50 M(-2.0%) |
| Dec 2021 | $466.66 M(-4.7%) | $127.04 M(-3.9%) |
| Sep 2021 | - | $132.20 M(+20.7%) |
| Jun 2021 | - | $109.52 M(+11.9%) |
| Mar 2021 | - | $97.90 M(-27.6%) |
| Dec 2020 | $489.67 M(-31.5%) | $135.20 M(+23.8%) |
| Sep 2020 | - | $109.18 M(-2.1%) |
| Jun 2020 | - | $111.54 M(-16.6%) |
| Mar 2020 | - | $133.74 M(-24.2%) |
| Dec 2019 | $714.59 M(+47.8%) | $176.38 M(-7.5%) |
| Sep 2019 | - | $190.61 M(+7.5%) |
| Jun 2019 | - | $177.29 M(+4.1%) |
| Mar 2019 | - | $170.32 M(+3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $483.51 M(+77.0%) | $164.50 M(+27.8%) |
| Sep 2018 | - | $128.75 M(+14.8%) |
| Jun 2018 | - | $112.15 M(+43.6%) |
| Mar 2018 | - | $78.12 M(+10.9%) |
| Dec 2017 | $273.15 M(+70.5%) | $70.45 M(-5.3%) |
| Sep 2017 | - | $74.37 M(+5.0%) |
| Jun 2017 | - | $70.85 M(+23.3%) |
| Mar 2017 | - | $57.48 M(+2.0%) |
| Dec 2016 | $160.16 M(+69.2%) | $56.38 M(+48.1%) |
| Sep 2016 | - | $38.06 M(+8.7%) |
| Jun 2016 | - | $35.01 M(+14.0%) |
| Mar 2016 | - | $30.71 M(+7.3%) |
| Dec 2015 | $94.65 M(+179.9%) | $28.61 M(+18.8%) |
| Sep 2015 | - | $24.08 M(-3.9%) |
| Jun 2015 | - | $25.06 M(+48.3%) |
| Mar 2015 | - | $16.90 M(+36.7%) |
| Dec 2014 | $33.81 M(+85.0%) | $12.36 M(+30.5%) |
| Sep 2014 | - | $9.47 M(+53.0%) |
| Jun 2014 | - | $6.19 M(+6.9%) |
| Mar 2014 | - | $5.79 M(+1.3%) |
| Dec 2013 | $18.28 M(+89.8%) | $5.71 M(+26.5%) |
| Sep 2013 | - | $4.52 M(-2.9%) |
| Jun 2013 | - | $4.66 M(+37.4%) |
| Mar 2013 | - | $3.39 M |
| Dec 2012 | $9.63 M | - |
FAQ
- What is Sage Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Sage Therapeutics?
- What is Sage Therapeutics annual operating expenses year-on-year change?
- What is Sage Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Sage Therapeutics?
- What is Sage Therapeutics quarterly operating expenses year-on-year change?
What is Sage Therapeutics annual total operating expenses?
The current annual operating expenses of SAGE is $442.31 M
What is the all time high annual operating expenses for Sage Therapeutics?
Sage Therapeutics all-time high annual total operating expenses is $714.59 M
What is Sage Therapeutics annual operating expenses year-on-year change?
Over the past year, SAGE annual total operating expenses has changed by -$188.44 M (-29.88%)
What is Sage Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of SAGE is $91.67 M
What is the all time high quarterly operating expenses for Sage Therapeutics?
Sage Therapeutics all-time high quarterly total operating expenses is $190.61 M
What is Sage Therapeutics quarterly operating expenses year-on-year change?
Over the past year, SAGE quarterly total operating expenses has changed by $0.00 (0.00%)